As the field evolves, its crucial for healthcare leaders and organizations to stay agile, adapt to new trends, and focus on what matters most for patients and providers, namely: GLP1s are now firstline therapies: Adoption has accelerated from just 3% in 2021 to more than 23% in 2025, displacing longstanding generics like metformin
In one study, 87.6% of patients being injected with 2.4 mg of semaglutide experienced adverse events, including gastrointestinal issues in 63.5% of patients
During your consultation, your healthcare provider will assess your medical history, current health condition, and treatment goals to determine if semaglutide is an appropriate option for you
Patients will be shipped medication from a pharmacy located in Baton Rouge, Pharmaceutical Specialties
Ready To Book Your Lipotropic Injections Appointment
Follow us on social media for updates, tips, and patient success stories: